Researchers have found that chemicals produced by some vegetables could help maintain a healthy gut and prevent colon cancer.
A valuable cache of brain cancer biomedical data, termed REMBRANDT, has been made freely accessible to researchers worldwide.
A marker, termed KIM-1, in the blood could be utilized to predict the risk of developing renal cell carcinoma.
Ministers have agreed to the national screening committee’s recommendation for colorectal cancer screening in England in future to start earlier at 50 years of age.
Specific genes associated with triple-negative breast cancer risk have been identified by multigene hereditary cancer panel testing.
The largest ever study of its kind has become the first to definitively show an increased risk of blood cancers in relatives of patients.
A multi-disciplinary team of researchers have developed comprehensive CAR T-cell therapy pediatric guidelines.
The US FDA has approved Progenics Pharmaceuticals’ Adzera®, a first-in-class treatment for two rare adrenal tumors: pheochromocytoma and paraganglioma.
Findings demonstrate the potential of T2-weighted MRI in dual imaging and radiotherapy systems that aim to image and treat tumors simultaneously.
Researchers have discovered that diabetic women face a dramatically increased chance of developing mouth cancer.